BIOGEN INC. Overview
Company Headquarters: Massachusetts, US
Founded: 1978
Workforce: 7,800
Company Working:
Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurological and neurodegenerative diseases worldwide. The company offers drugs for the treatment of multiple sclerosis, plaque psoriasis spinal muscular atrophy, non-Hodgkin's lymphoma, Chronic Lymphocytic Leukemia (CLL), and among other conditions. The company offers products through its sales force and marketing groups. It has strategic collaborations with Ionis Pharmaceuticals to develop drug candidates for neurological diseases. The company was formerly known as Biogen Idec Inc. and changed its name to Biogen Inc. in March 2015. The firm has a strong presence in North America, Europe, Asia-Pacific, and
Strategy
Biogen Inc. focuses on expanding the business by partnerships with other companies. The company also focuses on optimizing the drug development process to gain maximize profits. Moreover, it also focuses on improve its ability to innovate in biomedical R&D.
